Cargando…
Acute Mountain Sickness Symptom Severity at the South Pole: The Influence of Self-Selected Prophylaxis with Acetazolamide
INTRODUCTION: Acetazolamide, a carbonic anhydrase inhibitor, remains the only FDA approved pharmaceutical prophylaxis for acute mountain sickness (AMS) though its effectiveness after rapid transport in real world conditions is less clear. METHODS: Over 2 years, 248 healthy adults traveled by airplan...
Autores principales: | Harrison, Michael F., Anderson, Paul J., Johnson, Jacob B., Richert, Maile, Miller, Andrew D., Johnson, Bruce D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744068/ https://www.ncbi.nlm.nih.gov/pubmed/26848757 http://dx.doi.org/10.1371/journal.pone.0148206 |
Ejemplares similares
-
Physiological variables associated with the development of acute mountain sickness at the South Pole
por: Harrison, Michael F, et al.
Publicado: (2013) -
Anuric Acute Kidney Injury Induced by Acute Mountain Sickness Prophylaxis With Acetazolamide
por: Neyra, Javier A., et al.
Publicado: (2014) -
Identifying the lowest effective dose of acetazolamide for the prophylaxis of acute mountain sickness: systematic review and meta-analysis
por: Low, Emma V, et al.
Publicado: (2012) -
Incidence and Symptoms of High Altitude Illness in South Pole Workers: Antarctic Study of Altitude Physiology (ASAP)
por: Anderson, Paul J., et al.
Publicado: (2011) -
Efficacy of acetazolamide for the prophylaxis of acute mountain sickness: A systematic review, meta-analysis, and trial sequential analysis of randomized clinical trials
por: Gao, Daiquan, et al.
Publicado: (2021)